Company / Operating Cash Flow per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.37
FY2025
5-year range
-$1.17 / -$0.37
FY2021-FY2025
Trend
+48.1%
vs FY2024
Sector context
#145 of 161
Health Care
What the data says
Among 161 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 10% for operating cash flow per share. Operating Cash Flow per Share has increased for 3 consecutive years, from $-1.17 in FY2022 to $-0.37 in FY2025.
Based on SEC 10-K filings.
-0.37 in FY2025.
Improved from $-1.02 to $-0.37 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 161This company -$0.37 Sector average $6.64
▼
-105.6% below sector average
Key checks
Key Insights
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 48.1% year-over-year.
- Ranks #145 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.37 | +48.1% |
| FY2024 | -$0.71 | +30.1% |
| FY2023 | -$1.02 | +12.8% |
| FY2022 | -$1.17 | -115.2% |
| FY2021 | -$0.54 | -588.6% |
| FY2020 | $0.11 | +121.7% |
| FY2019 | -$0.51 | +10.1% |
| FY2018 | -$0.57 | +21.6% |
| FY2017 | -$0.73 | +14.2% |
| FY2016 | -$0.85 | -110.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026